news
Scientists in Japan have discovered a promising new biomarker –…
10 May 2018 | By Drug Target Review
Scientists in Japan have discovered a promising new biomarker – cytoskeleton-associated protein 4 (CKAP4) – for lung cancer, potentially transforming the way the disease is diagnosed and treated.